As per our new research report “Global Protein Therapeutics Market Analysis”, the global protein therapeutics market is one of the most prolific and fastest growing markets in the world. These therapies are progressively playing a major role in the development of treatments for some of the most widespread maladies all around the world. Besides the technological advancements, the industry is being boosted by various factors, such as growing population and increasing prevalence of chronic and communicable diseases. Moreover, the people are now being able to go for such therapies due to the rising penetration of the medical insurance industry. Due to all these factors, the global protein therapeutics market will continue to grow at a high CAGR of around 12% during 2011-2013.
Our reports depicts that the efficacy and rising adoption of these therapies by the people is attracting more investments in the industry, both by large and small players. The companies are also giving due attention to the R&D regarding the protein therapies, with majority of the work being done related to diseases, such as Cancer, HIV/AIDS, and neurological disorders. Linked to the research work being done, the number of clinical trials related to the therapies will also witness a rise in near future.
Through prudent and in-depth analysis, we have covered all the major segments of the protein therapeutics market, such as Monoclonal Antibodies, Insulin, Interferon, Granulocyte Colony Stimulating Factor, Human Growth Hormone, Erythropoietins, Blood Clotting Factor, and Follicle Stimulating Hormone. Within each segment, we have provided information regarding the market size of the segment, application areas, key players in each segment, and growth forecasts till 2013.
|
